• Biofrontera held its annual shareholder meeting on June 11, 2026.
• Shareholders backed an amended and restated 2021 Omnibus Incentive Plan, lifting the share authorization to 8,750,000 from 3,750,000.
• Shareholders ratified CBIZ CPAs as independent registered public accounting firm for the fiscal year ending Dec. 31, 2026.
• Stockholders also selected Beth J. Hoffman, Ph.D. and Kevin D. Weber as Class II directors, with terms running to the 2029 annual meeting.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biofrontera Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-029079), on June 17, 2026, and is solely responsible for the information contained therein.